Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warning Letter Review Suggests Aggressive Action Needed, Troy Says

This article was originally published in The Tan Sheet

Executive Summary

The FDA Office of Chief Counsel's review of warning and untitled letters suggests the agency should be taking more aggressive enforcement actions, Chief Counsel Daniel Troy suggested Feb. 21
Advertisement

Related Content

GMP Compliance – Not Investment – Impresses FDA, Chief Counsel Says
GMP Compliance – Not Investment – Impresses FDA, Chief Counsel Says
GMP Compliance – Not Investment – Impresses FDA, Chief Counsel Says
Warning Letter Review By FDA Chief Counsel’s Office Will Take Five Days
Warning Letter Review By FDA Chief Counsel’s Office Will Take Five Days
Warning Letter Review By FDA Chief Counsel’s Office Will Take Five Days
B.F. Ascher Halts Supplement/OTC Combo Sales Following FDA Warnings
B.F. Ascher Halts Supplement/OTC Combo Sales Following FDA Warnings
Allen, Azar & Troy: FDA Legal Partners Streamline Enforcement Activity

Topics

Advertisement
UsernamePublicRestriction

Register

PS093688

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel